Meeting Format and Agenda
Prior to this event, each faculty member will be asked to complete a case-based Consensus or Controversy (CoC) survey designed to document his or her usual approach to a variety of clinical scenarios and management questions provided by a group of 5 community-based medical oncologists. During the program, the responses of the faculty to specific CoC questions will be graphically displayed for the audience. Short didactic presentations will also be included to provide a formal review of available data and ongoing trials.
MODULE 1: Optimal Treatment Strategies for Patients with Localized HER2-Positive Breast Cancer (BC) — Dr Hurvitz
MODULE 2: Current Role of Genomic Assays in the Management of ER-Positive Early BC — Dr Burstein
MODULE 3: Therapeutic Considerations for Patients with ER-Positive, HER2-Negative Metastatic BC (mBC) — Dr Di Leo
MODULE 4: Protocol and Nonresearch Decision-Making for Patients with HER2-Positive mBC — Dr Sledge
MODULE 5: Role of PARP Inhibition in the Management of BC — Dr Robson
MODULE 6: Immune Checkpoint Inhibitors and Other Emerging Therapeutic Strategies — Dr Rugo
Target Audience:
This program is intended for medical oncologists, hematology-oncology fellows and other allied healthcare professionals involved in the treatment of breast cancer.
Learning Objectives and Goals:
At the conclusion of this activity, participants should be able to:
CME Credit Form:
A CME credit form will be given to each participant at the conclusion of the activity.
Accreditation Statement:
Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement:
Research To Practice designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Policy:
Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess conflicts of interest with faculty, planners and managers of CME activities. Conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the RTP scientific staff and an external, independent physician reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations. Financial disclosures will be provided in meeting course materials.
Supporters:
This activity is supported by educational grants from AbbVie Inc, AstraZeneca Pharmaceuticals LP, Genentech BioOncology, Genomic Health Inc, Lilly and Merck.
Hilton Chicago
720 South Michigan Avenue
Chicago, IL 60605
Hotel Phone: (312) 922-4400
Meeting Room:
Grand Ballroom (Level 2)
Directions:
The Hilton Chicago hotel is located just 5 minutes (2.5 miles) north of the McCormick Place convention center.
Thank you for your interest in our educational program. At this time, online preregistration is closed. However, seats are still available for the conference. Onsite registration will be open starting at 6:30 PM (Central Time) on Monday, June 4th. If you are interested in attending, please visit our registration desk in the Grand Ballroom foyer located on the second level of the Hilton Chicago (720 Michigan Avenue, Chicago, IL).
Please note, onsite registrant seating will be prioritized for healthcare professionals directly involved in the treatment of patients. If you have any questions, please feel free to contact us via email at: Meetings@ResearchToPractice.com or call (800) 233-6153.